About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
Biocon-Media
  > MEDIA
  Overview
  Press Releases
  Media Stories
  Download Center
  Video Gallery
  Photo Gallery
  Media Contacts
  
  
     
 

Press Releases

2020 2019 2018 2017
2016 2015 2014 2013 2012 2011
2010 2009 2008 2007 2006 2005

 
  June 2020
22 June Biocon Pharma and DKSH Collaborate to commercialize seven generic formulations in South East Asia markets Download Pdf
12 June Biocon and Mylan Announce U.S. FDA Approval of Semglee™ (insulin glargine injection) Download Pdf
01 June Kiran Mazumdar-Shaw Wins EY World Entrepreneur of the Year™ 2020 Award Download Pdf
01 June Biocon's* Partner Mylan Receives Favourable Ruling from U.S. PTAB on Sanofi's Four Device Patents for Lantus® SoloSTAR® Download Pdf
  May 2020
27 May Biocon Biologics Receives DCGI Approval for Emergency Use of CytoSorb® to Treat Critical COVID-19 Patients U.S. FDA recently approved CytoSorb for emergency use in COVID-19 patients Download Pdf
19 May Biocon Biologics Receives EU GMP Certification for Multiple Biosimilars Manufacturing Facilities in Bengaluru; Expands its Manufacturing Capacity Includes Drug Substance and Drug Product Facilities for Pegfilgrastim, Trastuzumab, and Bevacizumab Download Pdf
14 May Biocon Earnings Q4FY20 Revenue Up 6% at Rs 1,644 Cr; EBITDA Down 11% at Rs 382 Cr; Net Profit Down 42% at Rs 123 Cr Download Pdf
12 May Company Statement: Biocon Biologics Drug Substance Facilities in Bengaluru Receive EU GMP Certification Download Pdf
08 May Company Statement: Biocon Receives EIR for Small Molecules API Manufacturing Facility for Pre -Approval and GMP U.S. FDA Inspection Download Pdf
  April 2020
27 Apr Biocon and Mylan Launch Fulphila®, Biosimilar Pegfilgrastim, in Canada Download Pdf
27 Apr Press Note: Kiran Mazumdar-Shaw Recognized among World's Top 20 Inspirational Leaders in Biopharmaceuticals in The Medicine Maker 'Power List 2020' Download Pdf
16 Apr Company Statement: Biocon Biologics Receives EIR from U.S. FDA for Two Manufacturing Facilities, Inspection Stands Closed Download Pdf
14 Apr Biocon and Mylan Launch Fulphila®, Biosimilar Pegfilgrastim, in Australia Download Pdf
01 Apr Biocon's Insulin Manufacturing Facility in Malaysia Receives EIR from U.S. FDA with Voluntary Action Indicated (VAI) Classification, Inspection Stands Closed Download Pdf
  March 2020
27 Mar Biocon & Biocon Biologics Ensuring Manufacturing of Life-Saving Medicines for Patients, Partners and Customers Download Pdf
20 Mar Company Statement: Biocon Receives EIR for Small Molecules API Manufacturing Facility for Post - Approval and GMP U.S. FDA Inspection Download Pdf
11 Mar Biocon & Mylan Win Patent Litigation Asserted by Sanofi for Insulin Glargine Device Patent in U.S. Download Pdf
09 Mar U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Bevacizumab for Review Download Pdf
  February 2020
27 Feb Company Statement: Biocon's Small Molecules API Manufacturing Facility Completes Post-Approval and GMP U.S. FDA Inspection Download Pdf
22 Feb Company Statement: Biocon's Insulin Manufacturing Facility in Malaysia Completes U.S. FDA (PAI) Inspection Download Pdf
20 Feb Kiran Mazumdar-Shaw Named EY Entrepreneur of the Year India 2019 Download Pdf
  January 2020
27 Jan Company Statement: Biocon's Small Molecules API Manufacturing Facility Completes Pre-Approval and GMP U.S. FDA inspection Download Pdf
23 Jan Biocon Q3FY20 Earnings Revenue at Rs 1,784 Cr, Up 14%; EBITDA at Rs 480 Cr, Up 18%; Net Profit (before exceptional item) at Rs 225 Cr, Up 6% Download Pdf
20 Jan Company Statement: Biocon's Oral Solid Dosage Manufacturing Facility Completes Pre-Approval U.S. FDA lnspection with Zero Observations Download Pdf
19 Jan Kiran Mazumdar-Shaw Honoured with Order of Australia, Australia's Highest Civilian Honour Download Pdf
06 Jan True North to Invest Rs 536.25 Crore in Biocon Biologics for 2.44% Stake Download Pdf
06 Jan Biocon Biologics Appoints M.B. Chinappa as Chief Financial Officer Download Pdf
   
 
 
 
 
     
  Biocon

Businesses

Recommended sites Biocon on  
  Home
About Us

Investor Relations
Media Relations
Careers
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

ABLE
Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
       
  Report adverse event/side effects and product complaints    
       
  * Disclaimer            © 2018, Biocon. All Rights Reserved